A new FDA survey finds some positive trends among young people in the US, though new forms of nicotine use like pouches have become a bit more popular.
On top of the risks of injecting untested and potentially contaminated products, user error may make this runaway wellness fad even more dangerous.
A standardized framework for regulating the safety and efficacy of AI in healthcare has yet to be established.
The National Institutes of Health, Senior Health reports that approximately 76 million Americans get food poisoning, or food-borne illnesses, …
Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and serotonin, promising fewer side effects.
Ivím Health reports a federal panel has recommended BPC-157, a popular peptide, be available through licensed compounding pharmacies with a prescription.
TelyRx reports a survey of 1,000+ users highlights misconceptions about online pharmacy safety, revealing that trust is growing despite confusion over FDA regulation.
Kivo reports that over half of new FDA-approved drugs are now for rare diseases, thanks to the Orphan Drug Act of 1983, which incentivized their development.
A new FDA fast-track program could undermine the agency’s role as a global drug safety authority.
Kivo reports that while new drug shortages in the U.S. have declined, existing shortages are lasting longer, impacting critical medications like injectables.